Glifempa 25mg tablets contain empagliflozin, which lowers blood glucose by increasing urinary glucose excretion through inhibition of the sodium-glucose co-transporter 2 (SGLT2).
In appropriate patients, empagliflozin also reduces the risk of cardiovascular events, heart failure hospitalization, and progression of chronic kidney disease.
Treatment should be combined with healthy lifestyle measures and regular monitoring.
Uses
- Type 2 diabetes mellitus
- Heart failure (when prescribed)
- Chronic kidney disease (when prescribed)
Active Ingredient
- Empagliflozin 25mg
How to Take
- Take one tablet once daily, with or without food, exactly as prescribed.
Precautions
- Prescription-only medicine.
- Maintain adequate hydration.
- Monitor kidney function regularly.
- Inform your healthcare provider if symptoms of urinary or genital infections occur.
